You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK — French biotechnology firm GenoScreen said on Monday that it has received CE-IVD marking for its Deeplex Myc-TB kit for the prediction of tuberculosis antibiotic susceptibility and resistance.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.